Enteric Disease Testing Market Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Enteric Disease Testing Market |
Microorganisms such as viruses, bacteria, and parasites
enter the body through the mouth and cause enteric diseases. These pathogens
can be acquired through contaminated food and water, or by coming into contact
with the faeces of an infected animal or person. The most common symptoms of
enteric diseases are abdominal cramps, vomiting, nausea, and anorexia, which
can result in fluid and nutrient loss from the body. Advances in diagnostic
technologies have revolutionised enteric disease testing in recent years,
significantly increasing detection rates in symptomatic individuals.
The global burden of enteric disease infection can result in
significant health-care costs and even death. Each year, one of the enteric
diseases, typhoid salmonellosis, accounts for 16 million new cases and
approximately 600,000 deaths. The only way to deal with this burden is to
detect enteric diseases early.
Traditional culture methods are being replaced by tests that
can diagnose illness quickly, such as enzyme immunoassay (EIA), PCR-based
tests, and dipstick-based tests, which are labour intensive and time consuming.
One of the major factors driving the enteric
disease testing market is rising demand for rapid diagnostic tests. Molecular
Diagnostics, Monoclonal Antibodies, Immunoassays, Differential Light
Scattering, Information Technology, Artificial Intelligence, Liposomes, Flow
Cytometry, Chromatography, Diagnostic Imaging, Gel Microdroplets, and Others
are the segments of the global enteric disease testing technology market. Molecular
diagnostics is an emerging technology in enteric diseases that is expected to
grow faster than other technologies.
Comments
Post a Comment